Our R&D team chases bold goals. The therapies and solutions that no one else has achieved or even attempted. And we want to be there first. That's what we go after every day for our patients.
Q&A: Hacking genetic information to treat disease.
Explore how we harness the power of AI to find new treatments for diseases with large unmet need.
Learn how AbbVie researchers find and advance ideas that have the potential to cure.
See how AbbVie goes beyond the numbers to increase representation in clinical trials.
Watch how AbbVie’s Specialized Research in Chaotic Systems (SPaRCS) team is breaking barriers to advance the development of new therapies.
Watch how we are working to harness technology, data and real-life experiences to create the medicines of the future.
Scientist Michelle Crouthamel describes how her lab integrates biosensors and wearables to bring clearer insights about medicine we’re developing.
An inside look at the creation of a search engine to help solve science’s toughest questions.
When it comes to creating more time for patients with debilitating diseases, AbbVie’s goals are ambitious—and they need to be.
In oncology, immunology, virology and beyond, researchers strive to turn science into breakthrough medicines. See how in AbbVie’s Discovery Files series.
In R&D, operations and beyond, employees do what’s good for patients, people and the planet
Precision medicine explained: Breaking down how this unique approach and commitment could fundamentally change how we treat disease.
What have we learned about degradomers?
With the most complete human genome sequenced yet, AbbVie’s Genomics Research Center aims to find out.
Get an inside look at our largest data initiative
5 courageous voices on why investment in new medicines matters.
5 ways to be an ally for women in science
Discovering and developing new medicines is not easy. But it’s an aspiration that drives our science and is the foundation of this company.
Data convergence is anything but dull when you pair a veteran data scientist with a leader who connected human genome reading to clinical care.
Meet the team whose job is to solve problems before they exist
An AbbVie researcher shares how her own struggles with uterine fibroids influenced her perspective as a doctor and scientist.
Why science is a team sport and failure isn’t all bad, says AbbVie’s new Chief Scientific Officer.
Why is it important for people to see a rheumatologist sooner rather than later?
An AbbVie leader in patient-centered research helps us to hear and consider the patient voice.
What's the impact from cleaner, faster chemical reactions?
Although randomization may always be the gold standard, Big Data is breathing new life into clinical trial design.
Whether a molecule acts like a “lobster” or “crayfish” may predict its ability to one day become a medicine.
Discovering a new medicine isn’t easy. When robots couldn’t help, three scientists found a way.
Understand the future of packaging and how it’s evolving to be more about the patient.
A genetic pioneer reveals what he learned from mapping his own genome.
Can you quantify the value of moments that matter? How patient experiences change the equation.
Medical records and insurance claims data help companies, regulators, payers and physicians better understand how medicines perform in the real world.